These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16276153)

  • 21. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Topical treatment of skin diseases of childhood. Part II. Special therapy].
    Horáková M
    Cesk Pediatr; 1981 Aug; 36(8):470-4. PubMed ID: 7273230
    [No Abstract]   [Full Text] [Related]  

  • 23. Topical treatments: a simple guide.
    Greenhow MM
    Nursing (Lond); 1983 Feb; 2(10):281-4. PubMed ID: 6554497
    [No Abstract]   [Full Text] [Related]  

  • 24. [Urea in topical therapy of skin diseases--principles and use].
    Wohlrab WA
    Z Arztl Fortbild (Jena); 1993 Aug; 87(8):643-50. PubMed ID: 8379203
    [No Abstract]   [Full Text] [Related]  

  • 25. Topical Therapy Primer for Nondermatologists.
    Jewell JR; Myers SA
    Med Clin North Am; 2015 Nov; 99(6):1167-82. PubMed ID: 26476246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Special features of topical and systemic dermatologic therapy in children].
    Lukas A; Wolf G; Fölster-Holst R
    J Dtsch Dermatol Ges; 2006 Aug; 4(8):658-78; quiz 679-80. PubMed ID: 16895569
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of topical calcipotriol on inflammatory linear verrucous epidermal nevus.
    Micali G; Nasca MR; Musumeci ML
    Pediatr Dermatol; 1995 Dec; 12(4):386-7. PubMed ID: 8747593
    [No Abstract]   [Full Text] [Related]  

  • 28. Can we still suggest the topical cyclosporin treatment in cutaneous disorders?
    Vena GA; Cassano N
    J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):18-9. PubMed ID: 11451314
    [No Abstract]   [Full Text] [Related]  

  • 29. [Item no 174: prescription and surveillance of steroidal and non-steroidal anti-inflammatory agents: dermal corticoid treatment].
    Ann Dermatol Venereol; 2005 Oct; 132(10 Suppl):7S156-7S159. PubMed ID: 16419539
    [No Abstract]   [Full Text] [Related]  

  • 30. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic/treatment modalities.
    Weber R
    Dermatol Nurs; 2005 Aug; 17(4):304-5. PubMed ID: 16206688
    [No Abstract]   [Full Text] [Related]  

  • 32. Viva questions from the IJDVL. Topical corticosteroids.
    Viswanath V; Vasani R
    Indian J Dermatol Venereol Leprol; 2016; 82(2):240-5. PubMed ID: 26924414
    [No Abstract]   [Full Text] [Related]  

  • 33. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Area of skin disease can be used to indicate amount of treatment needed.
    Long CC; Finlay AY
    BMJ; 1996 Sep; 313(7058):690. PubMed ID: 8811778
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of topical maxacalcitol for acquired perforating disorder.
    Yoshiya H; Okuyama R; Uhara H
    J Am Acad Dermatol; 2013 Jun; 68(6):e181-2. PubMed ID: 23680211
    [No Abstract]   [Full Text] [Related]  

  • 36. Topical Drug Innovation From 2000 Through 2014.
    Walter JR; Xu S
    JAMA Dermatol; 2015 Jul; 151(7):792-4. PubMed ID: 25807060
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
    Puglia C; Bonina F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):429-41. PubMed ID: 22394125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued use of nonsteroidal topical treatments: comment on the FDA talk paper.
    Wolf R; Parish JL; Marcus BS; Parish LC
    Skinmed; 2005; 4(3):133-4. PubMed ID: 15891246
    [No Abstract]   [Full Text] [Related]  

  • 40. [External agents for the care and treatment of the skin].
    Fröhlich HH
    Pharm Unserer Zeit; 1979 Nov; 8(6):179-88. PubMed ID: 538049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.